LLY compared with CELU: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

CELUCelularity Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

CELUCelularity Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,407.25· pre 1,422.28· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

CELUCelularity Inc

0.81· pre 0.81· delayed

Pre-marketNov 4 '26delayed

Mkt cap$26.5MRevenue$4MQ1 FY26Revenue—

Compare

Pre-marketNov 4 '26delayed

LLYELI Lilly & Co

CELUCelularity Inc

1,407.25pre 1,422.28delayed

Price

0.81pre 0.81delayed

$1.3T

Mkt cap

$26.5M

Q3 FY26$24.4B

Revenue

$4MQ1 FY26

FY25$65.2B

Revenue

—

LLY1,407.25vsCELU0.81Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

LLY, solidCELU, dashed

Supply-chain overlap

Revenue flow

CELU: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No disclosed counterparties: CELU.

Only CELU 0

None

Role chip = supplier or customerSource: SEC EDGAR